Hyperuricemia may causally contribute to PAH, positioning uric acid as a potential therapeutic target for treatment and prevention. Mendelian randomization analysis suggests a genetic-level causal ...

Glaucoma patients show slower visual response times, indicating impaired visual signal processing rather than motor or attention deficits. The study involved glaucoma patients and healthy controls ...

People with MS show significantly worse vascular function, especially increased arterial stiffness, compared with healthy controls. A medium effect size was found for vascular health deterioration ...

A panelist discusses how comprehensive care coordination between specialists, proactive adverse effect management, and innovative care models can optimize treatment outcomes for Lambert-Eaton ...

Sikander Ailawadhi, MD, discusses how the 2024 ASH Annual Meeting’s “Prospective Patient Preference Study for BTKi Treatment Attributes in CLL and SLL” explored the factors influencing ...

Wendy Cheng, PhD, MPH, discusses how the study on the efficacy of gepotidacin vs nitrofurantoin in a nitrofurantoin-resistant population (a pooled analysis of the EAGLE-2 and EAGLE-3 trials) aimed ...

In 2024, the field of myasthenia gravis (MG) saw many developments from clinical trials of new treatments, including batoclimab, which have shown promise in improving patient outcomes, as well as ...

The VET PFAS Act could help older veterans with toxic exposure attain the medical treatment they need by expanding eligibility. However, the stark reality is that current laws fail to be inclusive ...

Third-generation CAR T-cell therapy shows promising efficacy and safety in heavily pretreated CLL patients, with a 67% complete response rate. The new CAR T-cell generation aims to mitigate ...

Panelists discuss how emerging data on odronextamab in diffuse large B-cell lymphoma suggest its potential to play a significant role in therapy, with promising results that may position it ...

The individual behavior of a patient’s myeloproliferative neoplasm (MPN) will determine how the disease is monitored and managed in the long term, explained Jennifer Vaughn, MD, of The Ohio ...

Panelists discuss how iron deficiency anemia significantly impacts patients’ quality of life through symptoms like chronic fatigue, shortness of breath, and cognitive dysfunction, while also ...